{"name":"Hackensack Meridian Health","slug":"hackensack-meridian-health","ticker":"","exchange":"","domain":"hackensackmeridianhealth.org","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Decitabine plus Fludarabine and Busulfan","genericName":"Decitabine plus Fludarabine and Busulfan","slug":"decitabine-plus-fludarabine-and-busulfan","indication":"Other","status":"phase_1"},{"name":"Stem Cell Educator Therapy","genericName":"Stem Cell Educator Therapy","slug":"stem-cell-educator-therapy","indication":"Other","status":"phase_1"},{"name":"Ceftriaxone treatment","genericName":"Ceftriaxone treatment","slug":"ceftriaxone-treatment","indication":"Other","status":"marketed"},{"name":"LICEMD","genericName":"LICEMD","slug":"licemd","indication":"Other","status":"phase_2"},{"name":"Tamsulosin - 3 days","genericName":"Tamsulosin - 3 days","slug":"tamsulosin-3-days","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"18F-rhPSMA-7.3","genericName":"18F-rhPSMA-7.3","slug":"18f-rhpsma-7-3","indication":"PET imaging of PSMA-positive lesions in men with prostate cancer","status":"marketed"},{"name":"Fludarabine monophosphate, melphalan, Bortezomib","genericName":"Fludarabine monophosphate, melphalan, Bortezomib","slug":"fludarabine-monophosphate-melphalan-bortezomib","indication":"Relapsed or refractory multiple myeloma","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Convalescent Plasma","genericName":"Convalescent Plasma","slug":"convalescent-plasma","indication":"COVID-19 (severe or life-threatening disease)","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Ketamine Injectable Product","genericName":"Ketamine Injectable Product","slug":"ketamine-injectable-product","indication":"Induction and maintenance of anesthesia","status":"marketed"}]}],"pipeline":[{"name":"Decitabine plus Fludarabine and Busulfan","genericName":"Decitabine plus Fludarabine and Busulfan","slug":"decitabine-plus-fludarabine-and-busulfan","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Stem Cell Educator Therapy","genericName":"Stem Cell Educator Therapy","slug":"stem-cell-educator-therapy","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"18F-rhPSMA-7.3","genericName":"18F-rhPSMA-7.3","slug":"18f-rhpsma-7-3","phase":"marketed","mechanism":"18F-rhPSMA-7.3 is a fluorine-18 labeled imaging agent that binds to prostate-specific membrane antigen (PSMA) on prostate cancer cells to enable PET imaging detection.","indications":["PET imaging of PSMA-positive lesions in men with prostate cancer"],"catalyst":""},{"name":"Ceftriaxone treatment","genericName":"Ceftriaxone treatment","slug":"ceftriaxone-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Convalescent Plasma","genericName":"Convalescent Plasma","slug":"convalescent-plasma","phase":"phase_3","mechanism":"Convalescent plasma transfers antibodies and immune factors from recovered patients to provide passive immunotherapy against infectious disease.","indications":["COVID-19 (severe or life-threatening disease)","Emerging infectious diseases (investigational)"],"catalyst":""},{"name":"Fludarabine monophosphate, melphalan, Bortezomib","genericName":"Fludarabine monophosphate, melphalan, Bortezomib","slug":"fludarabine-monophosphate-melphalan-bortezomib","phase":"phase_2","mechanism":"Fludarabine monophosphate is a purine analog that interferes with DNA synthesis, melphalan is an alkylating agent that cross-links DNA, and Bortezomib is a proteasome inhibitor that blocks protein degradation.","indications":["Relapsed or refractory multiple myeloma","Mantle cell lymphoma"],"catalyst":""},{"name":"Ketamine Injectable Product","genericName":"Ketamine Injectable Product","slug":"ketamine-injectable-product","phase":"marketed","mechanism":"Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks glutamate signaling in the central nervous system.","indications":["Induction and maintenance of anesthesia","Analgesia and sedation","Treatment-resistant depression (off-label/emerging indication)"],"catalyst":""},{"name":"LICEMD","genericName":"LICEMD","slug":"licemd","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tamsulosin - 3 days","genericName":"Tamsulosin - 3 days","slug":"tamsulosin-3-days","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE4zOU1zT01IMG93R2NSMVZZMUVTS0l6N1Bybksza0FjM2U4N2JILVllMWVuZjRNMlpZYjI1a1Q1YTNpN09lUWdWek9ENWUwbktFampnWkl2dU5iend4SW0ydDZVWFdWUmYweFc3bUVtS1R5WDFsdGc?oc=5","date":"2026-01-15","type":"earnings","source":"Modern Healthcare","summary":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments - Modern Healthcare","headline":"JPM 2026, Day 4: Clover predicts a profit, plans tech investments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPTGhzYUs1bkNCSjJSZFlzM3A3QkRPcmYyeDVjMjVzSTFlNEVPZ1BJS0lONWdiVmw0bjFPQjhGcXNpNmlDU1hUSnpBRER0SFJyUmNRUU1SLWVDdUlfVVZoS0RMRFl3bzc5MndMME5ENW5tZXB6SFpFdHprNmJJazR3dTNGWVVKSEkzYkdSNkIxZW1SSE4tT2hRYVlGNmw?oc=5","date":"2026-01-13","type":"deal","source":"fiercehealthcare.com","summary":"JPM26, Day 2: Hackensack Meridian Health's ambulatory builds, partnerships; CommonSpirit talks divestitures, AI - fiercehealthcare.com","headline":"JPM26, Day 2: Hackensack Meridian Health's ambulatory builds, partnerships; CommonSpirit talks divestitures, AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNd012dE5QWnZUMTJ4Nm5hN09pbURvR0lEcmhNYWdtY29aRGE2b3o0ci1QNGhlN1g2VXRhUHlwekMwWGQ4V214OGp1cE9GZnJxa19HdnZOSms5Y0dZWkxVbXlCTDkzQ3d1cUpWZkhfbGZEclpRZ1Y4RkxRMHZLME93YkZjclo3d0lZX05nMXA1dXVjRTA3SlZ1UkJLdE9GdmF6OXIyOHdiWERBUUNwWFJtZkN1T21GZGVqRTQwTk1La1MwZ0o4?oc=5","date":"2025-10-09","type":"pipeline","source":"fiercehealthcare.com","summary":"Truepill co-founder's latest startup, Foundation Health, banks $20M to bring AI to pharmacy operations - fiercehealthcare.com","headline":"Truepill co-founder's latest startup, Foundation Health, banks $20M to bring AI to pharmacy operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORFZLMGFlbVZQdy05V2F1SkVkMTdQNTJXN0pRWU01N2JkUGZZbHNsekFHNGJ5V0xJLVNFTnExYWlEOHBBS0ZYanBRUVdSRWR6c0RXTlZBdXhYRndmY285MFFJN3d5Z0k1UFlfa0dFdm90WlRLbXMwX2h5S2xZYTViSUlaWFhzdEJRVXRjWHd3YXpjY1QwUlJyX3l3TjFhUkJ0b081VGZGeVBkd3F4cGx5V1VPZTEydTBoLU1oTGRtWDNjN2tXbzFpLUtXdjVjSmhZdDY5cDhieV8ta28?oc=5","date":"2025-09-22","type":"pipeline","source":"Insider NJ","summary":"HINJ Hosts HERHealth: Advancing Women’s Care from Motherhood to Menopause in Edison on September 26, 2025 - Insider NJ","headline":"HINJ Hosts HERHealth: Advancing Women’s Care from Motherhood to Menopause in Edison on September 26, 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-22","type":"pipeline","source":"Newswise","summary":"Hackensack Meridian CDI to Accelerate Lifesaving Antibiotic Discovery with New Federal $37.8M Grant | Newswise - Newswise","headline":"Hackensack Meridian CDI to Accelerate Lifesaving Antibiotic Discovery with New Federal $37.8M Grant | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQMlVzTl9vZWVGR2c2Rm9CcnlqU1YxbTI4YU5MbjZndFN4eld5WTk0SVYxNGUtTmNKVFVsS01Hc3hpblJFTUIxUXNGUG1YLUR5RmY2ZEVQVVFJR0tCME5fckk2OVRMWWwzQ0RCVXVVLXNtN3owSWN1Z3dYWFlUanFadk5rWlRBMS1GRTdaLUphQlBfNXdLazhFSHdiT2ZKbTdfeTVycndHcmtCdUFnLW9JUVZpbEdOaEVjOThZbXNSVU9lZWc?oc=5","date":"2025-06-13","type":"deal","source":"Binghamton University","summary":"SOPPS, HMH partnership celebrate resident’s graduation - Binghamton University","headline":"SOPPS, HMH partnership celebrate resident’s graduation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNWW11MUh4TzBvMFluTDEtVW1IMmhUTTZOX0RRcjZkeEtpdVk2SlJiWXNpTW5XYm9KeUdfWGcyd3ZvNld5NHBBMlowZGczX3pPVms1Z0d6R0RDcllQeGh0Vk1YaEU0X3hPZFU5VXIwd3dWMUZaUHFxbGlxa2NwWkM5b2k3U3lFbWxXZTVoZmdBZEpVbGpnM19PZ24ySGdaYXFaaFFPUFZ5bXE5Nk5lWWhkTXVoRTJ4UnBBZ0pRNzlCekJlM2M?oc=5","date":"2023-11-30","type":"pipeline","source":"Binghamton University","summary":"Binghamton’s pharmacy school continuing to form strong bonds with healthcare organizations - Binghamton University","headline":"Binghamton’s pharmacy school continuing to form strong bonds with healthcare organizations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPNUhKbHZtOEJxNU9sWTh2U19HbFc2TzVTeUNORWltVFNWWFIyY1hGU1BDRDB3S1k1bGRIX2FFMm5MOV9mQkxsNjBnWlBDU3JYQVZTM2k2c0ZCUDlqcl9SZnhNNmJZNmJOTjItMG4yQ0pKZlNvUFBJS0RjLVVmNGZLZQ?oc=5","date":"2023-07-24","type":"deal","source":"Hackensack Meridian Health","summary":"Alzheimer's Research Collaboration - Hackensack Meridian Health","headline":"Alzheimer's Research Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOOGFUVXVvaTFkRV9IdHpsQmtRTk1qYjY4cEM4bmNjaU9ZSWFPWm55VkRLTjFId0NteWZMUkk3UHIyZGFhMDh5enBmbVVfWHp5dHVkNWlrTUtfUW1hc1dfUVpRZTBQbl9UV3hiVldSSkxlWFJ2eVliaW5LazJSTzN5MmFIWGVNTklCaS14M0hYUGlhZkE?oc=5","date":"2023-05-03","type":"pipeline","source":"RE-NJ","summary":"Prism breaks ground on 80,000 sq. ft. Hackensack Meridian facility at ON3 - RE-NJ","headline":"Prism breaks ground on 80,000 sq. ft. Hackensack Meridian facility at ON3 - RE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNWVVRWm4yNjJFaFhXRVJqTWhzX011b1duMU9RMG00MktIc0otU1dQdzlGTm8zeGZCZHRaNHhzT2JnS25mVG1VRmwxdjVfZUZyRDN3bmN1NEttZnJIVnh0b3RiWWVOMllCM21pUFBWU0pfN1luQWJpSTJQVXpubFBXX0k2YUVYNUhhdUtMN0Rnak9ULWkzUUVfRmVNaGNwdjd0VlFuX0pGYXlfdDc4R2hzN1dYZzNtS0VOVlE?oc=5","date":"2022-01-11","type":"pipeline","source":"PR Newswire","summary":"FluidForm announces investment from Hackensack Meridian Health - PR Newswire","headline":"FluidForm announces investment from Hackensack Meridian Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxPa1A0ald1U19qMHp2UEFPNzVxc2dHSE82MmhqT09QSExTSHQ0WTdjVUlUekNWWTlJRUY0N0w1bTJvOGJUU3NEdkRpMHNVdkVaVTJGUDNSOU9yeVNmejU3NU44blJuS0ZCbHMxT2V2VHJOdDVyRUJQVHJEOXpfQW1uMkRCYWZTS2pLVU1RclZsTlNQRUpnbjc5ZC10dk4xWDk5eW1WSDNaRVpEeEFYTWVwNktseS1jTWRJck9lOTdieFV6VDFpMEc4THJENmZkQTUzQ1ZnTXRRX0NJZXFvUVR0ZmYzUl9abW9hUjVsM1d0aGkxSFhwa3o5SVN0elMzSzJlenJpRkllN2VWV2RnVl83SmJTZkZ2aV9ZSS13?oc=5","date":"2021-05-24","type":"pipeline","source":"PR Newswire","summary":"Hackensack Meridian Health and Eisai Inc. Join Forces to Support the Expansion of Alzheimer's Disease Detection and Services for Patients - PR Newswire","headline":"Hackensack Meridian Health and Eisai Inc. Join Forces to Support the Expansion of Alzheimer's Disease Detection and Serv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNTExhLS1SNm1WcGtxSURtODJqbmktajkwak5PeHA4MHJIOFowR29YV2pvUElTMUlSX0lZbWFfcmd0bFFiNXRBU0NFNDVNRkN0Q2JHelBvZnpCUFZMTDR5RmhNWGxHNkMxbEVUcm82Wm5xdk9KTG9STnBHMEI3WHJwMlg2X1YyTXJVU2E5SlplRk1oZFhQUG9iNDc4ZWlTcUZUcEhleGFXYzVpazlIZ3F6MFgzSE5aMmdyVWxxbEJzR0xJQWZEb29XUU1ROElVbmRIUEhQRkNqeFNPUVhvSW1aYjBtbzRvTHZqdDIyUXBvR3E3QzZJaFlqM29oRkgzNkE?oc=5","date":"2020-07-07","type":"pipeline","source":"New Jersey Business Magazine","summary":"Hackensack Meridian School of Medicine at Seton Hall University - Former Pharma Site Maintains Might - New Jersey Business Magazine","headline":"Hackensack Meridian School of Medicine at Seton Hall University - Former Pharma Site Maintains Might","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_1":3,"marketed":3,"phase_3":1,"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}